Back to search
FDAFDA · Food and drugs·Recall number Z-2069-2012

IMPAX CV Reporting The Results Management (RM)/IMPAX CV reporting component facilitates the quick, effective creating of digital structured reports for : adult catheterization and echocardiography, pediatric echocardiography, congenital heat disease, nuclear cardiology and non-invasive vascular disease management. This webb-based application allows cardiology departments to view, edit and sign the structured reports.

Published August 1, 2012 · Recall initiated: July 10, 2012

Summary

FDA records medical device Class II recall Z-2069-2012, published August 1, 2012 and initiated July 10, 2012. Recalling firm: AGFA Corp.; Status: Terminated; Reported quantity: 6; Lot: Software Version: RM 2.03 to 2.08, NIV 1.0. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

When users selected "Left stenosis" in the "Graft Duplex Conclusion" section in IMPAX CV Reporting Non-Invasive(NIV) module, "Right stenosis" appeared in the sentence display within the printed representation of the report.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AGFA Corp.
Distributor
Nationwide Distribution including IN, SC, OH, TX
Lot
Software Version: RM 2.03 to 2.08, NIV 1.0
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was IMPAX CV Reporting The Results Management (RM)/IMPAX CV reporting component facilitates the quick, effective creating of digital structured reports for : adult catheterization and echocardiography, pediatric echocardiography, congenital heat disease, nuclear cardiology and non-invasive vascular disease management. This webb-based application allows cardiology departments to view, edit and sign the structured reports. recalled?

Yes. FDA published recall Z-2069-2012 on August 1, 2012. Reported hazard: When users selected "Left stenosis" in the "Graft Duplex Conclusion" section in IMPAX CV Reporting Non-Invasive(NIV) module, "Right stenosis" appeared in the sentence display within the printed representation of the report.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone